Clarium, a healthcare technology company, recently announced a successful $10.5 million funding round led by General Catalyst, with support from Kaiser Permanente Ventures and other investors. The funding brings Clarium’s total capital raised to $16 million. The company unveiled Astra OS, an AI-powered platform designed to help healthcare providers optimize their supply chain operations and realize significant cost savings.
With plans to expand its team and integrate with key partners, Clarium aims to revolutionize the healthcare industry by addressing challenges in inventory management, demand planning, data accuracy, and workforce efficiency. By leveraging AI technology, Clarium’s Astra OS empowers hospitals to improve visibility, collaboration, and resiliency across all departments. The platform’s suite of applications, including Disruption Monitor and Substitute Manager, help hospitals proactively manage inventory and streamline operations.
Since implementing Astra OS, Clarium’s partner health systems have reported an average of over $10 million in cost savings and productivity gains in their supply chain operations. By reducing disruption resolution time, decreasing substitute approval time, and increasing clinically validated substitutes approved, Clarium is making a significant impact on the industry.
Steve Liou, Founder and CEO of Clarium, expressed optimism about the transformative potential of Astra OS, highlighting its ability to optimize spend, enhance workforce productivity, and improve patient outcomes. Reva Nohria, partner at General Catalyst, emphasized the importance of Astra OS in creating resilient supply chains and driving supply chain efficiency.
Jacqueline Epright, Vice President of Supply Chain at Yale New Haven Health, praised Clarium’s AI technology for its role in unifying data and providing predictive insights. With ongoing expansion and innovation, Clarium is poised to continue revolutionizing healthcare supply chain operations and improving patient care.
Source
Photo credit pulse2.com